Delayed autoimmune haemolytic anaemia after artesunate therapy for severe malaria.
Mostafa M AbohelwaVeena AgusalaMona HassanAmal GharamtiPublished in: BMJ case reports (2022)
We report the case of a 51-year-old man with severe malaria, who developed delayed autoimmune haemolytic anaemia following artesunate therapy. Delayed autoimmune haemolytic anaemia following artesunate therapy has been previously described. Its diagnosis can be challenging in the setting of possible dengue coinfection. Clinicians should be vigilant of this potential side effect of artesunate therapy, especially in patients who later develop signs and symptoms of haemolytic anaemia.